Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake”

被引：0

作者：

Francesco Cicone

Luciano Carideo

Claudia Scaringi

Giuseppe Minniti

机构：

[1] “Magna Graecia” University of Catanzaro,Unit of Nuclear Medicine, Department of Experimental and Clinical Medicine

[2] University Campus “Salvatore Venuta”,Unit of Nuclear Medicine, Sant’Andrea Hospital, Department of Surgical and Medical Sciences and Translational Medicine

[3] Sapienza University of Rome,Radiation Oncology Unit

[4] UPMC Hillman Cancer Center,Unit of Radiotherapy, Department of Medical, Surgical and Neuro Sciences

[5] San Pietro Hospital FBF,undefined

[6] University of Siena,undefined

来源：

Annals of Nuclear Medicine | 2020年 / 34卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：230 / 231

页数：1

共 50 条

[31] A high 18F-FDOPA uptake is associated with a slow growth rate in diffuse Grade II-III gliomas
Isal, Sibel
Gauchotte, Guillaume
Rech, Fabien
Blonski, Marie
Planel, Sophie
Chawki, Mohamad B.
Karcher, Gilles
Marie, Pierre-Yves
Taillandier, Luc
Verger, Antoine
BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1084):
[32] Functional assessment of non-metastatic paraganglioma and pheochromocytoma by 18F-FDopa PET: Impact of tumor localization and genetic status
Cerdan, F.
Gabriel, S.
Sebag, F.
Fakhry, N.
Deveze, A.
Barlier, A.
Cammilleri, S.
Mundler, O.
Taieb, D.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2013, 37 (04): : 116 - 123
[33] Correlation of Standardized Uptake Value Derived Indices with Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice
Janvier, L., Jr.
Verger, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S601 - S601
[34] Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment
van Beek, Andre P.
de Heide, Loek J. M.
van Ginkel, Bram
Slart, Riemer H. J. A.
van der Horst-Schrivers, Anouk N. A.
Boellaard, Ronald
de Vries, Elisabeth G. E.
Noordzij, Walter
Glaudemans, Andor W. J. M.
CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 163 - 168
[35] Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study
Kwon, Yeongkeun
Yoon, Hanseok
Ha, Jane
Lee, Hyeon-seong
Pahk, Kisoo
Kwon, Hyunwoo
Kim, Sungeun
Park, Sungsoo
FRONTIERS IN ENDOCRINOLOGY, 2025, 16
[36] Correlating kinetic 18F-FDOPA uptake to quantitative MRI markers in primary and metastatic brain tumors to predict patient outcomes with hybrid PET/MRI
Aboian, Mariam
Barajas, Ramon
Ravanfar, Vahid
Bahroos, Emma
Tong, Elizabeth
Braunstein, Steven
Cha, Soonmee
Hernandez-Pampaloni, Miguel
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[37] Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A 18F-FDOPA PET/CT study
Amodru, Vincent
Romanet, Pauline
Scemama, Ugo
Montava, Marion
Fakhry, Nicolas
Sebag, Frederic
Castinetti, Frederic
Lavieille, Jean-Pierre
Loundou, Anderson
Varoquaux, Arthur
Barlier, Anne
Pacak, Karel
Taieb, David
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1565 - 1571
[38] Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas
Oughourlian, Talia C.
Yao, Jingwen
Schlossman, Jacob
Raymond, Catalina
Ji, Matthew
Tatekawa, Hiroyuki
Salamon, Noriko
Pope, Whitney B.
Czernin, Johannes
Nghiemphu, Phioanh L.
Lai, Albert
Cloughesy, Timothy F.
Ellingson, Benjamin M.
JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (01) : 135 - 145
[39] Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas
Talia C. Oughourlian
Jingwen Yao
Jacob Schlossman
Catalina Raymond
Matthew Ji
Hiroyuki Tatekawa
Noriko Salamon
Whitney B. Pope
Johannes Czernin
Phioanh L. Nghiemphu
Albert Lai
Timothy F. Cloughesy
Benjamin M. Ellingson
Journal of Neuro-Oncology, 2020, 147 : 135 - 145
[40] Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET
Kaiser, Lena
Quach, S.
Zounek, A. J.
Wiestler, B.
Zatcepin, A.
Holzgreve, A.
Bollenbacher, A.
Bartos, L. M.
Ruf, V. C.
Boening, G.
Thon, N.
Herms, J.
Riemenschneider, M. J.
Stoecklein, S.
Brendel, M.
Rupprecht, R.
Tonn, J. C.
Bartenstein, P.
von Baumgarten, L.
Ziegler, S.
Albert, N. L.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (08) : 2371 - 2381

← 1 2 3 4 5 →